Search

Author/Creator Firatli Tuglular, T.

1. Nivolumab for relapsed or refractory Hodgkin lymphoma: Experience in Turkey. (June 2017)

Authors:
Ferhanoglu, B.; Bekoz, H.; Karadurmus, N.; Paydas, S.; Gulbas, Z.; Turker, A.; Toptas, T.; Firatli Tuglular, T.; Tekgunduz, E.; Kaya, A.; Tastemir, N.; Arat, M.; Pepedil Tanrikulu, F.; Ozkocaman, V.; Abali, H.; Turgut, M.; Kaynar, L.; Karadogan, I.; Ozbalak, M.; Dogu, M.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
321
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. P1227: POLATUZUMAB VEDOTIN, RITUXIMAB, AND BENDAMUSTINE COMBINATION IN RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A REAL-WORLD DATA FROM TURKEY. (23rd June 2022)

Authors:
Dal, M. S.; Uncu Ulu, B.; Uzay, A.; Akay, O. M.; Besisik, S.; Yenerel, M. N.; Celik, S.; Kaynar, L.; Yucel, O. K.; Deveci, B.; Sonmez, M.; Mehtap, O.; Bekoz, H. S.; Sunu, C.; Salim, O.; Ulas, T.; Karti, S.; Altuntas, F.; Ferhanoglu, B.; Firatli Tuglular, T.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1113
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search